about
[Low adherence to 2009 pandemic influenza A(H1N1) vaccination program among health care workers of a medical centre during the pandemic phase].In vivo imaging of the fine structure of rhodamine-labeled macaque retinal ganglion cells.Biodiversity differences between managed and unmanaged forests: meta-analysis of species richness in Europe.Patient risk factors for developing a drug-related problem in a cardiology ward.Pre-transplant donor-specific T-cell alloreactivity is strongly associated with early acute cellular rejection in kidney transplant recipients not receiving T-cell depleting induction therapyExclusion of T Cells From Pancreatic Carcinomas in Mice Is Regulated by Ly6C(low) F4/80(+) Extratumoral MacrophagesSpatial Bayesian belief networks as a planning decision tool for mapping ecosystem services trade-offs on forested landscapes.Protection from the acquisition of Staphylococcus aureus nasal carriage by cross-reactive antibody to a pneumococcal dehydrogenaseImpact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosaCommunity-acquired pneumonia caused by methicillin-resistant Staphylococcus aureus in critically-ill patients: systematic review.Preformed frequencies of cytomegalovirus (CMV)-specific memory T and B cells identify protected CMV-sensitized individuals among seronegative kidney transplant recipients.Normalization of creatine kinase values in a case of rhabdomyolysis during daptomycin treatmentComparative Population Plasma and Tissue Pharmacokinetics of Micafungin in Critically Ill Patients with Severe Burn Injuries and Patients with Complicated Intra-Abdominal InfectionPlasma and peritoneal fluid population pharmacokinetics of micafungin in post-surgical patients with severe peritonitis.What is the effect of obesity on piperacillin and meropenem trough concentrations in critically ill patients?Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonate.Low Non-structured Antiretroviral Therapy Interruptions in HIV-Infected Persons Who Inject Drugs Receiving Multidisciplinary Comprehensive HIV Care at an Outpatient Drug Abuse Treatment Center.Urinary micafungin levels are sufficient to treat urinary tract infections caused by Candida spp.[Infections related to parenteral nutrition catheter]Pharmacokinetics of micafungin in patients with pre-existing liver dysfunction: A safe option for treating invasive fungal infections.Comparative pharmacokinetic and pharmacodynamic response of single and double intraruminal doses of ivermectin and moxidectin in nematode-infected lambs.Plasma and cerebrospinal fluid concentrations of linezolid in neurosurgical critically ill patients with proven or suspected central nervous system infections.Comparative effects of olive oil-based and soyabean oil-based emulsions on infection rate and leucocyte count in critically ill patients receiving parenteral nutrition.Factors associated with adherence to guidelines for the use of tigecycline in a tertiary care hospital.Off-label prescription of tigecycline: clinical and microbiological characteristics and outcomes.[Differences in the use of tigecycline between ICU patients and non-ICU patients].Comment on: Pharmacokinetics of high dosage of linezolid in two morbidly obese patients.Differences in pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin between three different CMS dosage regimens in a critically ill patient infected by a multidrug-resistant Acinetobacter baumannii.Effective removal of colistin methanesulphonate and formed colistin during intermittent haemodialysis in a patient infected by polymyxin-only-susceptible Pseudomonas aeruginosa.Epidemiology of acute respiratory disease at the Pediatric Emergency Room of the Social Security Medical Center in Panama City, Panama.Asymmetric sulfoxidations mediated by alpha-chymotrypsin.Molecular and Functional Noninvasive Immune Monitoring in the ESCAPE Study for Prediction of Subclinical Renal Allograft Rejection.Micafungin concentrations 100 mg daily in plasma and burn eschars in patients with severe burn injuries.Design of a score to identify hospitalized patients at risk of drug-related problems.Risk of side effects associated with the use of nevirapine in treatment-naïve patients, with respect to gender and CD4 cell count.Five Years of Multidisciplinary Care in Hereditary Cancer: Our Experience in a Spanish University Hospital.Evaluation of ultra- and nanofiltration for refining soluble products from rice husk xylan.Preformed circulating HLA-specific memory B cells predict high risk of humoral rejection in kidney transplantation.Membrane-assisted processing of xylooligosaccharide-containing liquors.Satellite telemetry informs PCB source apportionment in a mobile, high trophic level marine mammal: the ringed seal (Pusa hispida).
P50
Q30399929-9563A4D0-F8A6-4B7D-88B8-2E56BF8F9BC6Q33313071-E8444156-968C-4975-BA61-1BB13E9F7ED8Q33528131-17E9B550-96BB-4178-AC4B-C5661F867B69Q34764219-3F7009EA-DE66-4E05-8EA0-97A782007A0FQ35092328-4BE860A4-D5D2-4962-BF35-6489E8F67A00Q35772377-7C829D35-197A-44A3-B5AC-003D825E872FQ35849252-8B1A6632-D3A4-4EBD-A497-A6035CCA1D1AQ36187255-D3782542-7DB4-45E8-99B2-1BA52C27648CQ36240813-0024792A-0C63-4651-8677-4E080CA19AE1Q36290694-8A2F6309-54CB-49E7-9937-F8E3BDE43FE8Q36293963-C8A1BEBB-E1D8-421F-9C8C-6AF373CEFB00Q36865495-4A99040A-085B-4B55-ADC6-BB277C8B782CQ37287812-C6ABB755-EF50-41A5-9C2B-2AE4188A5942Q39031509-7F568BE9-B771-4A74-A0C3-F38B2C5351A6Q40172540-B8439AE1-5E4B-488C-8EBE-D8A39B0CAD2FQ40356202-115B7359-B8C3-479D-9C82-BCEBD6D18110Q40477509-ED640626-15E0-4A1E-B684-5FED247403B4Q40610921-C5F602AA-5E2F-4A90-91C1-29B3B837F2EFQ40614908-44BF39C1-DA4D-4FDD-9F10-5CC3F8311DB8Q41326325-9F5F067B-448C-4E4D-A325-1A2E28324BA9Q41479060-9C4E99D4-9429-4B14-9154-4C3B4097FDBEQ41741402-80F6267A-055D-4468-9D47-3E4B742B0933Q42519797-F137DCD0-51A7-43F0-A818-2BBFE0985C78Q42788440-416AC4E8-CB9C-4BF3-B0AF-FEC0E4F9B950Q42911865-25DCD418-9F3E-454D-A30A-6A8621CB336FQ43013573-614BD350-322B-4193-8617-A525D2BAB23AQ44424597-78CA9FCC-22E4-4822-ADCB-68535167004BQ44429348-8B3751B6-EED3-42F0-87B9-901522A16BA3Q44617742-506B11D7-5BA1-4A5D-8D1D-373F3D4A06BBQ45265913-98BF649C-5233-4746-83CC-DF73DDCEA327Q45714351-EC727799-20F1-473A-A198-9DADE5C4E1EDQ46011313-669F2C22-0785-41A8-97FA-B6D3A08F5EBEQ46072543-2E16D628-BFEE-444E-B9F4-68ACB6635192Q46155882-9D84D13B-5789-4C45-B725-26DFF6400D1BQ46805408-6489E93C-9B05-4466-81BF-267A3E2BC55CQ47629726-2FB18263-7231-436F-95CE-5A1DF3AAB52EQ48009146-018A5943-F11D-47A9-9BFB-446D70F504D2Q50722278-623A2416-F42E-4271-94ED-C388FD838305Q51161984-2D48B3C0-86D0-4C86-A6C1-52E2650E5B9EQ51401977-C5F1284F-BFE8-423D-8D5F-1B89A86F6E18
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sonia Luque
@ast
Sonia Luque
@en
Sonia Luque
@es
Sonia Luque
@nl
type
label
Sonia Luque
@ast
Sonia Luque
@en
Sonia Luque
@es
Sonia Luque
@nl
prefLabel
Sonia Luque
@ast
Sonia Luque
@en
Sonia Luque
@es
Sonia Luque
@nl
P106
P31
P496
0000-0002-3215-320X